Human adipose tissue‐derived mesenchymal stem cells improve cognitive function and physical activity in ageing mice
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Brain ageing leads to atrophy and degeneration of the cholinergic nervous system, resulting in profound neurobehavioral and cognitive dysfunction from decreased acetylcholine biosynthesis and reduced secretion of growth and neurotrophic factors. Human adipose tissue‐derived mesenchymal stem cells (ADMSCs) were intravenously (1 × 10 6 cells) or intracerebroventricularly (4 × 10 5 cells) transplanted into the brains of 18‐month‐old mice once or four times at 2‐week intervals. Transplantation of ADMSCs improved both locomotor activity and cognitive function in the aged animals, in parallel with recovery of acetylcholine levels in brain tissues. Transplanted cells differentiated into neurons and, in part, into astrocytes and produced choline acetyltransferase proteins. Transplantation of ADMSCs restored microtubule‐associated protein 2 in brain tissue and enhanced Trk B expression and the concentrations of brain‐derived neurotrophic factor and nerve growth factor. These results indicate that human ADMSCs differentiate into neural cells in the brain microenvironment and can restore physical and cognitive functions of aged mice not only by increasing acetylcholine synthesis but also by restoring neuronal integrity that may be mediated by growth/neurotrophic factors. © 2013 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545 · cited 3×
“Cholinergic nerve cells in the basal forebrain undergo neurodegenerative changes during normal ageing as well as in Alzheimer’s disease (AD; Bartus et al., 1982; Grothe et al., 2012).”
BackgroundAlzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627 · cited 2×
“Progressive loss of cholinergic neurons, marked by reduced choline acetyltransferase (ChAT) activity leading to decreased acetylcholine (ACh) release and p75 neurotrophin receptor expression, occurs during ageing and AD (Whitehouse et al., 1982; Bierer et al., 1995; Mufson et al., 2002; Gil-Bea et al., 2005; Roman and…”
BackgroundNerve Growth Factor Signaling, Neuroprotection, and Neural Repair
Sofroniew, M. V., Howe, C. L., & Mobley, W. C. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1217 · Cited by 1,284
Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans
Herndon, L. A., Schmeissner, P. J., Dudaronek, J. M., Brown, P. A., Listner, K. M., Sakano, Y., Paupard, M. C., Hall, D. H., & Driscoll, M. (2002) · Nature · doi:10.1038/nature01135 · Cited by 1,214 · cited 1×
“Ageing diminishes motor performance (Freeman and Gibson, 1988), and body movement declines gradually with increasing age in studies using Caenorhabditis elegans (Herndon et al., 2002).”
BackgroundTerry, A. V., & Buccafusco, J. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041616 · Cited by 1,159
Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia.
Román, G. C., & Kalaria, R. N. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.004 · Cited by 213
Aging, stress and the hippocampus
Miller, D. B., & O’Callaghan, J. P. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.002 · Cited by 206
The Recent Understanding of the Neurotrophin’s Role in Skeletal Muscle Adaptation
Sakuma, K., & Yamaguchi, A. (2011) · BioMed Research International · doi:10.1155/2011/201696 · Cited by 120 · cited 2×
“…motor coordination (Strand et al., 2007; Boger et al., 2011) but also by NGF upregulating cholinergic activity (Pongrac and Rylett, 1998; Oosawa et al., 1999; Auld et al., 2001), because neurotrophins, including BDNF and NGF, play roles in skeletal muscle adaptation (Sakuma and Yamaguchi, 2011).”
BackgroundAlterations of the blood-brain barrier in cerebral white matter lesions in the ageing brain
Simpson, J. E., Wharton, S. B., Cooper, J., Gelsthorpe, C., Baxter, L., Forster, G., Shaw, P. J., Savva, G., Matthews, F. E., Brayne, C., et al. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.063 · Cited by 77
Dopamine, Acetylcholine, and Glutamate Interactions in Aging Behavioral and Neurochemical Correlates
FREEMAN, G. B., & GIBSON, G. E. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb32984.x · Cited by 35
Cited by
A review of physical and cognitive interventions in aging
Bamidis, P. D., Vivas, A. B., Styliadis, C., Frantzidis, C., Klados, M., Schlee, W., Siountas, A., & Papageorgiou, S. G. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.019 · Cited by 358
Alzheimer’s disease, dementia, and stem cell therapy
Duncan, T., & Valenzuela, M. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0567-5 · Cited by 338
Mesenchymal Stem Cell Therapy and Alzheimer’s Disease: Current Status and Future Perspectives
Kim, J., Lee, Y., Lee, S., Kim, K., Song, M., & Lee, J. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200219 · Cited by 73
“…levels, and cholinergic nervous system marker expressions were upregulated, and cognitive function and physical activities were markedly improved [78]. iPSCs therapy iPSCs are pluripotent stem cells reprogrammed from somatic cells with four transcription factors (Oct4, Sox2, Klf4, and c-Myc)…”
Self-citationStem cell therapy in Alzheimer’s disease: possible benefits and limiting drawbacks
Alipour, M., Nabavi, S. M., Arab, L., Vosough, M., Pakdaman, H., Ehsani, E., & Shahpasand, K. (2019) · Molecular Biology Reports · doi:10.1007/s11033-018-4499-7 · Cited by 63
Berrío Sánchez, J., Cucarian Hurtado, J., Barcos Nunes, R., & de Oliveira, A. A. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0011 · Cited by 7
Metadata
- Authors
- Park, D., Yang, G., Bae, D. K., Lee, S. H., Yang, Y., Kyung, J., Kim, D., Choi, E., Choi, K., Kim, S. U., Kang, S. K., Ra, J. C., & Kim, Y.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2013-02-13
- Volume
- 91
- Issue
- 5
- Pages
- 660-670
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W1992201222
- Cited by
- 97
- References
- 10
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.